Industries BiotechnologyClinical TrialsMachine LearningTherapeuticsHeadquarters Regions Greater Boston Area, East Coast, New England Founded Date 2017 Founders Andrew Noh, Eric Alm, James Burgess, Mark Smith, Tom Borody, Zain Kassam Operating Status Active Last Funding Type Series D Also Known As NextBiome, Finch Scientific Legal Name Finch Therapeutics Group, Inc.
Stock Symbol NASDAQ:FNCH Company Type For Profit
Contact Email info@finchtherapeutics.com Phone Number (617) 229-6499
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs.
The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in
patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models.
Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.